ARDELYX, INC. ARDX

Latest FY: 2025 Healthcare Biotechnology
Market Price $3.72
Market Cap $918.95M
P/E Ratio N/A
Quick Peer Compare (Healthcare):
Revenue (FY 2025) ↑22.1% YoY
$407.32M
3-Yr CAGR: 98.4%
Net Income ↓-57.4% YoY
-$61.60M
Net Margin: -15.1%
Free Cash Flow ↑4.0% YoY
-$43.98M
FCF Yield: -4.79%
EPS (Diluted) ↓-52.9% YoY
$-0.26
Basic: $-0.26
Return on Equity Efficiency
-36.9%
ROA: -12.3%

📊 Multi-Year Historical Performance & Trends

Financial Performance History Revenue, Net Income & Free Cash Flow
Margins Trend (%) Gross, Operating & Net Margins
Balance Sheet Strength Cash, Debt & Equity
Cash Flow Generation Operating Cash Flow vs CapEx vs FCF

📈 Year-over-Year (YoY) Growth History (ARDX)

All monetary values in millions ($M)
Fiscal Year Revenue Revenue YoY Gross Profit Net Income Net Inc YoY Diluted EPS EPS YoY Div / Sh Div Yield Op. Cash Flow Free Cash Flow FCF YoY
FY 2016 $24.0M $-94.2M $-112.4M 0.00% $-92.5M $-97.4M
FY 2017 $42.0M +74.8% $33.6M $-64.3M +42.8% 0.00% $-65.2M $-67.5M +30.7%
FY 2018 $2.6M -93.8% $2.1M $-91.3M -41.9% 0.00% $-70.3M $-70.6M -4.5%
FY 2019 $5.3M +102.6% $4.7M $-94.9M -4.0% 0.00% $-76.5M $-76.8M -8.8%
FY 2020 $7.6M +43.4% $2.5M $-94.3M +0.7% 0.00% $-81.4M $-81.8M -6.4%
FY 2021 $10.1M +33.4% $5.6M $-158.2M -67.7% $-1.52 0.00% $-152.6M $-154.4M -88.9%
FY 2022 $52.2M +416.6% $48.0M $-67.2M +57.5% $-0.42 +72.4% 0.00% $-70.0M $-70.1M +54.6%
FY 2023 $124.5M +138.6% $106.7M $-66.1M +1.7% $-0.30 +28.6% 0.00% $-89.7M $-90.1M -28.5%
FY 2024 $333.6M +168.1% $283.1M $-39.1M +40.8% $-0.17 +43.3% 0.00% $-44.8M $-45.8M +49.1%
FY 2025 $407.3M +22.1% $367.8M $-61.6M -57.4% $-0.26 -52.9% 0.00% $-42.5M $-44.0M +4.0%
$

Valuation

Market Price $3.72
Market Cap $918.95M
Enterprise Value $1.05B
P/E Ratio N/A
P/B Ratio 5.50
FCF Yield -4.79%
Dividend Yield N/A
Shares Outstanding 247,029,400
%

Profitability & Margins

Gross Margin 90.29%
Operating Margin -10.06%
Net Margin -15.12%
Return on Equity (ROE) -36.90%
Return on Assets (ROA) -12.28%
Asset Turnover 0.81x
Revenue 3-Yr CAGR 98.40%
🛡️

Financial Health & Liquidity

Current Ratio 4.31
Cash Ratio 0.77
Debt / Equity 1.215
Debt / Assets 0.404
Cash & Equivalents $68.00M
Total Debt $202.83M
Book Value / Share $0.68
💧

Cash Flow Efficiency

Operating Cash Flow -$42.48M
Capital Expenditures (CapEx) $1.49M
Free Cash Flow -$43.98M
OCF / Revenue -10.43%
FCF / Revenue -10.80%
FCF 3-Yr CAGR N/A
🏷️

Per Share Metrics

EPS (Diluted) $-0.26
EPS (Basic) $-0.26
Dividends / Share N/A
Book Value / Share $0.68
EPS YoY Growth -52.94%
🏛️

Balance Sheet (FY 2025)

Total Assets $501.60M
Total Liabilities $334.65M
Stockholders' Equity $166.95M
Current Assets $382.32M
Current Liabilities $88.61M